Futura expects lower loss

AIM-quoted erectile dysfunction treatments developer Futura Medical says that its loss fell in 2010. Revenues generated from commercial payments from partners increased from £50,000 to £125,000. The loss fell from £1.51m to £1.32m. There is still £1m in the bank. The CSD500 condom still requires some points to be satisfied before it gets a CE mark and it can be launched by Futura's partner Reckitt Benckiser through its Durex brand. Futura has signed up Ansell as its partner for the PET500 enhanced sexual control product. The 2010 figures will be released in March. Futura Medical